iatroX logo
brainstormaskiatroX
knowledge centreblog
Knowledge Centre / Botulism

Botulism

Diagnosis and management of Clostridium botulinum toxicity.

Reviewed by Dr Kola Tytler MBBS CertHE MBA MRCGP (General Practitioner)
Last reviewed: 21 October 2025
Infectious DiseasesNeurologyPublic Health

Clinical Guidelines

Botulism - Guide for Healthcare Professionals - Canada.ca
National
Botulism - World Health Organization (WHO) Fact Sheet
National
Botulism (Clostridium botulinum) 2011 Case Definition | CDC
National
Botulism: clinical and public health management - GOV.UK
National
Clinical Guidelines for Diagnosis and Treatment of Botulism, 2021
National
Guidelines for the public health management of tetanus, botulism or anthrax among people who use drugs
National
Botulism
Local
Botulism: clinical and public health management
Local
Clinical Guidelines for Diagnosis and Treatment of Botulism, 2021
Local

Recent iatroX Q&As

  • What are the key clinical features to consider when diagnosing botulism in a patient presenting with neurological symptoms?Updated: 8/22/2025
  • How should I approach the management of a suspected botulism case in a primary care setting before hospital referral?Updated: 8/22/2025
  • What are the potential complications of botulism that I should monitor for in affected patients?Updated: 8/22/2025
askiatroX
privacytermshow it workscpdinsights
Download on the App StoreGet it on Google Play